DTHERA SCIENCES

CIK:0001586372|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
REVENUES	$ 6,485	$ 0	$ 6,485	$ 0
COST OF REVENUES
Cost of revenues	95,885	0	95,885	0
Impairment of inventory	16,019	0	16,019	0
TOTAL COST OF REVENUES	111,904	0	111,904	0
GROSS PROFIT	(105,419)	0	(105,419)	0
OPERATING EXPENSES
General and administrative	912,161	97,259	1,994,319	1,584,466
Sales and marketing	273,545	93,240	609,692	188,415
Research and development	64,377	66,940	142,565	158,274
TOTAL OPERATING EXPENSES	1,250,083	257,439	2,746,576	1,931,155
OPERATING LOSS	(1,355,502)	(257,439)	(2,851,995)	(1,931,155)
OTHER INCOME (EXPENSES)
Interest expense	(49,323)	0	(51,440)	(185,847)
Change in fair value of derivative liabilities	75,309	0	75,309	142,835
Loss on extinguishment of debt	0	0	0	(91,593)
Loss on disposal of fixed assets	0	0	(6,170)	0
Derivative expense	(305,398)	0	(305,398)	0
TOTAL OTHER EXPENSES	(279,412)	0	(287,699)	(134,605)
NET LOSS	$ (1,634,914)	$ (257,439)	$ (3,139,694)	$ (2,065,760)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING - Basic and diluted	2,572,762	1,510,462	2,500,169	954,805
Loss per common share - Basic and diluted	$ (0.64)	$ (0.17)	$ (1.23)	$ (2.16)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (3,139,694)	$ (2,065,760)
Adjustments for non-cash items:
Amortization of debt discount	41,118	172,655
Depreciation and amortization	31,079	766
Loss on disposal of fixed assets	6,170	0
Impairment of inventory	16,019	0
Loss on extinguishment of debt	0	91,593
Derivative expense	305,398	0
Gain on derivative liability	(75,309)	(142,835)
Common stock issued for services	123,632	0
Fair value of options vested	388,855	399,049
Changes in operating assets and liabilities:
Deferred cost of revenue	(9,655)	0
Inventory	(1,901)	0
Prepaid expenses	(513,307)	(10,167)
Deposits	(1,770)	0
Accounts payable and accrued liabilities	547,954	(45,482)
Deferred revenue	10,487	646
NET CASH USED IN OPERATING ACTIVITIES	(2,270,924)	(1,599,535)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property and equipment	(76,117)	(49,866)
Development of software	(259,721)	0
NET CASH USED IN INVESTING ACTIVITIES	(335,838)	(49,866)
CASH FLOWS FROM FINANCING ACTIVITIES
Common stock issuance	2,024,350	1,215,750
Exercise of stock options	31,806	0
Proceeds from notes payable	900,000	50,000
Proceeds from convertible notes	915,000	0
Payments on convertible notes	0	(240,000)
Payments on notes payable	0	(70,000)
Payments on notes payable, related party	0	(209)
Redemption of preferred stock	0	(82,690)
NET CASH PROVIDED BY FINANCING ACTIVITIES	3,871,156	1,786,853
NET CHANGE IN CASH	1,264,394	137,452
CASH AT BEGINNING OF PERIOD	303,483	12,191
CASH AT END OF PERIOD	1,567,877	149,643
Cash paid for interest	2,063	19,890
Cash received for interest earned	25	0
Cash paid for taxes	800	800
NON-CASH INVESTING AND FINANCING ACTIVITIES
Transfer of property and equipment to inventory	85,063	0
Adoption of ASU 2018-07	190	0
Debt discounts recorded on notes payable	456,535	0
Debt discounts recorded on convertible notes	1,100,000	0
Common stock issued with convertible notes	38,378	0
Common stock issued in extinguishment of debt	$ 0	$ 183,260

Condensed Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2018	Dec. 31, 2017
CURRENT ASSETS
Cash	$ 1,567,877	$ 303,483
Restricted cash	20,000	20,000
Inventory	70,945	0
Prepaid expenses	608,483	95,176
Deferred cost of revenue	9,655	0
Deposits	4,270	2,500
TOTAL CURRENT ASSETS	2,281,230	421,159
LONG TERM ASSETS
Property and equipment, net	45,599	77,365
Software development costs, net	245,292	0
TOTAL LONG TERM ASSETS	290,891	77,365
TOTAL ASSETS	2,572,121	498,524
CURRENT LIABILITIES
Accounts payable and accrued liabilities	984,424	436,472
Deferred revenue	12,287	1,800
Notes payable, net	559,582	0
Convertible notes payable, net	1	0
Derivative liabilities	1,106,711	0
TOTAL CURRENT LIABILITIES	2,663,005	438,272
TOTAL LIABILITIES	2,663,005	438,272
STOCKHOLDERS' EQUITY (DEFICIT)
Common stock 600,000,000 shares authorized; $0.001 par value; 2,667,602 and 2,352,166 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively	2,668	2,352
Additional paid in capital	7,583,279	4,594,847
Accumulated deficit	(7,676,831)	(4,536,947)
TOTAL STOCKHOLDERS' EQUITY (DEFICIT)	(90,884)	60,252
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 2,572,121	$ 498,524